Montazeri P, Fossati S, Clemente DBP, Cirugeda L, Elosua R, Fernandez-Barres S, Fochs S, Garcia-Esteban R, Marquez S, Pey N, Nawrot TS, Vrijheid M. Early-childhood BMI trajectories in relation to preclinical cardiovascular measurements in adolescence. J Dev Orig Hlth Dis. 2022 Jun;13(3):322-9. doi: 10.1017/S2040174421000441
Rives-Sanchez M, Quintos A, Prillaman B, Willes L, Swaminathan N, Niroula A, Alqsous N, Sharma S. Sleep disordered breathing in hospitalized African-Americans. J Natl Med Assoc. 2020 Jun;112(3):262-7. doi: 10.1016/j.jnma.2020.03.011
Li W, Zou T, Li L, Deng Y, Sun VT, Zhang Q, Layton B, Setoguchi S. Impacts of the North Atlantic subtropical high on interannual variation of summertime heat stress over the conterminous United States. Clim Dyn. 2019 Sep;53(5-6):3345-59. doi: 10.1007/s00382-019-04708-1
Wilson M, Lucas A, Cameron A, Luo M. Budget impact of adding vedolizumab to a health plan formulary as a first-line biologic option for ulcerative colitis and crohn's disease. Am Health Drug Benefits. 2018 Jul;11(5):253-62.
Wise LA, Troisi R, Hatch EE, Titus LJ, Rothman KJ, Harlow BL. Prenatal diethylstilbestrol exposure and reproductive hormones in premenopausal women. J Dev Orig Hlth Dis. 2015 Jun;6(3):208-16.
Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.
Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.
Lennert B, Bibeau W, Farrelly E, Sacco P, Schoor T. Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study. Am Health Drug Benefits. 2012 Sep;5(6):347-58.